Experimental variants | Treatments | |||||
---|---|---|---|---|---|---|
Control (PBS) | 102 | 104 | 106 | 108 | 1010 | |
Erythrocytes (x103 cell) | 0.70 ± 0.27 | 0.79 ± 0.11 | 0.79 ± 0.29 | 0.97 ± 0.43 | 0.83 ± 0.47 | 0.89 ± 0.24 |
Lymphocytes, % | 0.66 ± 0.56b | 0.43 ± 0.34b | 1.52 ± 1.01a | 1.87 ± 0.83 a | 1.93 ± 0.73 a | 2.24 ± 1.61 a |
Neutrophils, % | 0.20 ± 0.18c | 0.25 ± 0.15c | 0.28 ± 0.17c | 0.82 ± 0.81b | 0.84 ± 0.56b | 1.75 ± 0.50a |
Monocytes, % | 0.15 ± 0.19b | 0.99 ± 0.47a | 0.99 ± 0.73a | 1.15 ± 0.94a | 1.58 ± 0.83a | 1.61 ± 2.17a |
Thrombocytes, % | 0.33 ± 0.19ab | 0.51 ± 0.39b | 0.34 ± 0.16ab | 0.27 ± 0.17a | 0.22 ± 0.14a | 0.22 ± 0.15a |